Primary Immunodeficiency: Clinical Trials

2 trials for Primary Immunodeficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Terminated 2
Phase 22Terminated 2

Follow Primary Immunodeficiency: new trials by email Literature Review of Primary Immunodeficiency trials Research Report on Primary Immunodeficiency

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
Rimiducid, rivogenlecleucel - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child
Phase 1 / Phase 2TerminatedBellicum Pharmaceuticals1872017-01-012023-09-26
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant
BPX-501 T cells, Rimiducid - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child
Phase 1 / Phase 2TerminatedBellicum Pharmaceuticals1872014-04-012023-09-29

Narrower conditions

Anemia (2)  ·  Anemia, Aplastic (2)  ·  Anemia, Diamond-Blackfan (2)  ·  Anemia, Sickle Cell (2)  ·  Cytopenia (2)  ·  Fanconi Anemia (2)  ·  Hematologic Neoplasms (2)  ·  Hemoglobinopathies (2)  ·  Leukemia (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Myelodysplastic Syndromes (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Primary Immunodeficiency Diseases (2)  ·  Thalassemia (2)

Broader conditions

Anemia, Hemolytic (2)  ·  Anemia, Hemolytic, Congenital (2)  ·  Anemia, Hypoplastic, Congenital (2)  ·  Bone Marrow Diseases (2)  ·  Bone Marrow Failure Disorders (2)  ·  Congenital Bone Marrow Failure Syndromes (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  DNA Repair-Deficiency Disorders (2)  ·  Genetic Diseases, Inborn (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunologic Deficiency Syndromes (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia, Lymphoid (2)

Interventions

AP 1903 reagent (2)

Sponsors

Bellicum Pharmaceuticals (2)

Countries

Italy (2)  ·  United Kingdom (1)